Year: 2023

The Company downsizes certain head office personnel while retaining revenue generating staff WILMINGTON, Del., Oct. 26, 2023 (GLOBE NEWSWIRE) — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (the “Company” or “Onfolio”) announces it has implemented a number of cost-reducing measures designed to optimize operations and create greater financial efficiencies throughout the Company, including within its subsidiaries. Dominic Wells, Onfolio’s Chief Executive Officer, stated, “As a growing company, we regularly evaluate and adjust our corporate spending so we can continue to operate as an efficient organization. The measures we are announcing today, along with the potential acquisitions we will make with the $1 million raised last week and additional capital we seek to raise, will bring us significantly closer to...

Strong Organic Top-Line Growth Drives Financial Performance Operating highlights:  Three months ended   Nine months ended  September 30   September 30  2023   2022   2023   2022                               Revenues (millions) $ 1,117.1     $ 960.5     $ 3,255.3     $ 2,725.7  Adjusted EBITDA (millions) (note 1)   111.9       95.5       312.4       249.2  Adjusted EPS (note 2)   1.25       1.17       3.56       3.02                                 GAAP Operating Earnings   73.6       62.7       196.8       151.6  GAAP EPS   0.73       0.77       2.10       1.86                                 TORONTO, Oct. 26, 2023 (GLOBE NEWSWIRE) — FirstService Corporation (TSX: FSV; NASDAQ: FSV) today reported results for its third quarter ended September 30, 2023. All amounts are in US dollars. Consolidated...

LOUISVILLE, Ky., Oct. 26, 2023 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today announced that Philip S. Poindexter, President and T. Clay Stinnett, EVP and CFO will participate in the Hovde 2023 Financial Services Conference to be held November 1st through November 3rd, and will participate in a series of meetings with institutional investors. Management’s discussion materials to be used at this conference will be posted to the investor section of the Company’s website, www.syb.com, on or before November 1, 2023. Louisville, Kentucky-based Stock Yards Bancorp, Inc., with $7.9 billion in assets, was incorporated...

ATLANTA, Oct. 26, 2023 (GLOBE NEWSWIRE) — Speedemissions, Inc. (OTC Expert Market: SPMI) (the “Company”) a retail brand offering consumers automobile emissions testing and safety inspections, announced its unaudited financial results for the nine-month period ending September 30, 2023. “With the closing of our 2023 third quarter, we are pleased to report that the Company continues to focus on building financial strength as it has again posted positive EBITDA1 and net income which demonstrates the noteworthy progress made in the overall management and operation of our business. These gains are most impressive as they have been achieved in an environment of uncertainty caused by the post COVID-19 pandemic employment challenge. Our business has been affected, as we have faced unparallel issues with turnover and recruiting. To that...

VANCOUVER, British Columbia, Oct. 26, 2023 (GLOBE NEWSWIRE) — Interfield Global Software Inc. (NEO: IFSS) (the “Company”) is pleased to announce that its 100% owned site E-Commerce site Equipment Hound, the leading B2B e-commerce marketplace for industrial equipment, has enrolled Luca Mining Corp. (“Luca Mining”), a prominent leader in the Mexican mining sector, as a premium buyer member on the Equipment Hound platform. This strategic decision underscores Luca Mining’s commitment to sourcing the highest-quality equipment and expanding its reach within the global mining community. As a premium buyer member, Luca Mining gains exclusive access to an array of benefits meticulously designed to enhance its procurement efficiency and effectiveness on the Equipment Hound platform. These benefits encompass priority access to newly...

NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) — SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, November 7th, 2023. Participating on the call will be Phil Gomez, Chief Executive Officer, Dennis Hruby, Chief Scientific Officer, Dr. Jay Varma, Chief Medical Officer and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company’s website at www.siga.com under the ‘Events & Presentations’ tab in the Investor Relations section, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-888-886-7786 for domestic callers...

New interim NTLA-2001 clinical data to be presented at the 4th International ATTR Amyloidosis Meeting on November 2; data to include safety and both absolute and percent change in serum TTR reduction from cardiomyopathy and polyneuropathy arms of the study Intellia management to discuss latest NTLA-2001 data and share additional information about the upcoming Phase 3 study design at Q3 earnings webcast on November 9 at 8 a.m. ET     CAMBRIDGE, Mass., Oct. 26, 2023 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based technologies, today announced two upcoming events in November. NTLA-2001 Interim Clinical Data Update Intellia will present updated data from the ongoing NTLA-2001 Phase 1 study...

GAITHERSBURG, Md., Oct. 26, 2023 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its clinical program investigating pemvidutide for the treatment of NASH. NASH is a serious, potentially life-threatening condition that is a leading cause of liver failure and liver transplantation globally. NASH is a growing public health concern, and there are currently no approved treatments. The Fast Track designation is designed to facilitate the development and expedite the review of new drugs intended to treat serious conditions and address unmet medical needs. “The FDA’s decision was informed by the results of Altimmune’s studies including its Phase 1b randomized, placebo-controlled study of pemvidutide...